Y. Mootien, C. Fuchs, D. Narbey, M. Egard, P. Guiot; Hosp E. Muller, Mulhouse, France. Luo Choi Tateda, S. Kohno, M. Nagashima; AZM Studies Data Review Commit- tee, Tokyo, Japan. J. Templeton

54 SCIENTIFIC SESSIONS September 9-12 | ------------------------------------------------------------------------ 025 L1 Poster Session Antimicrobial Stewardship and OPAT Sunday, 11:30 a.m.–1:30 p.m. . . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: L1-282 Use of Conditional and Cumulative Susceptibility Reporting to Improve Antibiotic Prescribing and Rates of Initial Appropri- ate Antibiotic Therapy

S. C. Cheatham

1 , S. S. Utley 1 , M. R. Fleming 2 ; 1 St. Francis Health, India- napolis, IN, 2 Methodist Dallas Med. Ctr., Dallas, TX. L1-283 De-Escalation of Antibacterial Therapy in Urinary Tract Infections: A Neglected Opportunity to Save Broad-Spectrum Agents E. Montassier, E. Duchene, J. Caillon, G. Potel, E. Batard; Univ. de Nantes, Nantes, France. L1-284 The Incidence of Antimicrobial Associated Adverse Events During Outpatient Parenteral Antimicrobial Therapy OPAT: A One Year Retrospective Review I. El Lakkis, J. Mackey, M. Albrecht, R. Jambeih, E. Ablah, M. Sandid, K. Konda, M. Assi; Univ. of Kansas Sch. of Med. Wichita, KS. L1-285 Antibiotic Consumption in the Emergency Department: A 10-Year Survey E. Montassier, D. Navas, N. Goffinet, C. Gras-Le Guen, G. Potel, E. Batard; Ctr. Hosp. Univ. de Nantes, Nantes, France. L1-286 Antibiotic Algorithm Use in Sepsis: Adherence and Effective- ness in the Emergency Department T. C. Kam 1 , A. M. Cook 1 , J. L. Lock 1 , W. E. Swigart 1,2 , C. P. Bunce 1,3 ; 1 St. Vincent Hosp., Indianapolis, IN, 2 St. Vincent Emergency Physicians, Inc., Indianapolis, IN, 3 Infectious Disease of Indiana, Carmel, IN. L1-287 A Comparison of Ertapenem Versus Ceftriaxone for the Treatment of Cellulitis in the OPAT Setting R. Santos 1 , A. Mayhew 1 , D. Andrews 2 , A. L. Chapman 2 , M. Torok 3 ; 1 Cambridge Univ. Hosp. NHS Fndn. Trust, Cambridge, United Kingdom, 2 Royal Hallamshire Hosp., Sheffield, United Kingdom, 3 Univ. of Cambridge, Cambridge, United Kingdom. L1-288 Outpatient Parenteral Antibiotic Therapy OPAT: Experi- ence from a UK Teaching Hospital

S. V. Coggle

1 , E. Nickerson 1 , T. Gouliouris 1 , T. Corrah 1 , A. Mayhew 1 , R. Santos 1 , S. H. Aliyu 1 , A. J. Carmichael 1 , M. E. Torok 2 ; 1 Cambridge Univ. Hosp. NHS Fndn. Trust, Cambridge, United Kingdom, 2 Univ. of Cambridge, Cambridge, United Kingdom. ------------------------------------------------------------------------ 026 L1 Poster Session Respiratory Tract Infection Sunday, 11:30 a.m.–1:30 p.m. . . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: L1-289 In Routine Hospital Practice: Ertapenem in Comparison with Other Parenteral Antibiotics in the Treatment of Community- Acquired Pneumonia C. Hidalgo Tenorio, C. Santiago, A. Fernandez, C. Gil, V. Sotorrio, I. San- chez, C. Merin, A. Caballero, R. Javier, J. Pasquau Liaño; Univ. Hosp Virgen de las Nieves, Granada, Spain. L1-290 Inter-Country Differences in Microbiological Testing and Diagnoses for CAP in Hospitalized Patients: Results from the European REACH Study F. Blasi 1 , J. Garau 2 , J. Medina 3 , M. Ávila 4 , K. McBride 5 , H. Ostermann 6 ; 1 Univ.ersità degli Studi di Milano, Milan, Italy, 2 Hosp. Univ.ersitari Mutua de Terrassa, Barcelona, Spain, 3 AstraZeneca, Madrid, Spain, 4 AstraZeneca Eu- rope, Zaventem, Belgium, 5 Instat Services, Inc., Chatham, NJ, 6 Univ. Hosp. Munich, Munich, Germany. L1-291 Better Impact of Combination Therapy with Macrolides in ICU Patients with Community-Acquired Pneumonia

J. Y. Mootien, C. Fuchs, D. Narbey, M. Egard, P. Guiot; Hosp E. Muller, Mulhouse, France.

L1-292 Clinical Response Rate at Day 4 of Therapy in Hospitalized Adult Patients with Community-Acquired Bacterial Pneumonia CABP: An Interim Analysis of a Chart Review Study

R. Luo

1 , C. B. Lipkin 1 , F. R. Ernst 1 , X. Huang 2 ; 1 Premier, Charlotte, NC, 2 Forest Res. Inst., Jersey City, NJ. L1-293 Rainfall is a Risk Factor for Legionella pneumophila Pneumo- nia M. Labori, C. Garcia-Vidal, D. Viasus, L. Molero, D. Garcia-Somoza, J. Dorca, F. Gudiol , J. Carratala; Hosp. Univ. de Bellvitge, Barcelona, Spain. L1-294 A Phase 2, Multi-Dose, Double-Blind, Randomized, Multi- center, Comparative Study of Zabofloxacin vs Moxifloxacin in the Treatment of Mild to Moderate Community-Acquired Pneumo- nia

D. Choi

1 , Y. S. Kim 2 , M. J. Kim 3 , K. R. Back 4 , C. H. Lim 1 , J. A. Rock 5 , S. K. Seoung 1 ; 1 Dong-Wha Pharm., Yongin-si, Gyunggi-do, Korea, Republic of, 2 Asan Med. Ctr., Pungnap 2-dong, Songpa-gu, Seoul, Korea, Republic of, 3 Korea Univ. Anam Hosp., Anam-Dong 5-Ga, Seongbuk-Gu, Seoul, Korea, Republic of, 4 Samsung Med. Ctr., Irwon-dong, Gangnam-gu, Seoul, Korea, Republic of, 5 IASO Pharma Inc., San Diego, CA. L1-295 Is it Possible to Identify Legionella pneumophila Pneumonia from Initial Presentation on Emergency Room? C. Garcia-Vidal, D. Viasus, M. Labori, L. Molero, D. Garcia-Somoza, J. Dorca, F. Gudiol , J. Carratala; Hosp. Univ. De Bellvitge, Barcelona, Spain. L1-296 Dichotomy between In Vitro Activity and Clinical Outcome: Does Azithromycin AZM Demonstrate Clinical Efficacy in Macrolides Resistant Pneumococcal Pneumonia?

K. Tateda, S. Kohno, M. Nagashima; AZM Studies Data Review Commit- tee, Tokyo, Japan.

L1-297 The Impact of Statins on the Incidence of Bacteremia and Pneumonia in Military Personnel

K. R. Daniels

1 , I. A. Mansi 2 , J. P. Magulick 2 , C. U. Oramasionwu 3 , E. M. Mortensen 4 , M. V. Pugh 5 , C. R. Frei 1 ; 1 UT Austin UT Hlth. Sci. Ctr., San Antonio, TX, 2 San Antonio Military Med. Ctr., San Antonio, TX, 3 Univ. North Carolina, Chapel Hill, NC, 4 UT Southwestern, Dallas, TX, 5 VER- DICT, South TX Vet. Hlth. Care Syst, San Antonio, TX. L1-298 Usefulness of IDSAATS Guidelines Recommendations for Diagnostic Testing in Community-Acquired Pneumonia D. Viasus, C. Garcia-Vidal, J. Dorca, F. Gudiol, J. Carratalà; Hosp. de Bellvitge - IDIBELL, Univ. of Barcelona, L`Hosp. de Llobregat, Barcelona, Spain. 55 SUNDAY SCIENTIFIC SESSIONS Final Program L1-299 A Randomized Comparative Study of 7-Days Courses of Fuzafungine vs. Fuzafungine and Clarithromycin in Patients with Acute Laryngitis V. V. Rafalskiy 1 , A. S. Gurevitch 2 , I. V. Otvagin 1 , E. V. Dovgan 1 ; 1 Smolensk State Med. Academy, Smolensk, Russian Federation, 2 Bryansk Clinical and Diagnostic Ctr., Bryansk, Russian Federation. L1-300 Effect of Lacto Bacillus Rhamnosus LGG and Bifidobacterium animalis ssp Lactis BB-12 on Health-Related Quality of Life in College Students with Upper Respiratory Infections T. J. Smith, D. Rigassio-Radler, R. Denmark, R. Touger-Decker; Univ. of Med. and Dentistry of New Jersey, Newark, NJ. Late-breaker presentations are listed behind the Late-breaker tab of the Final Program. ------------------------------------------------------------------------ 027L2 Poster Session Studies in Sexually Transmitted Infection Sunday, 11:30 a.m.–1:30 p.m. . . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: L2-301 Prevalence and Correlates of Vaccine-Preventable Anal Hu- man Papillomavirus Genotypes in Australian Homosexual Men

D. J. Templeton

1 , S. N. Tabrizi 2 , D. A. Machalek 1 , F. Jin 1 , I. M. Poynten 1 , T. Tabone 2 , S. M. Garland 2 , R. J. Hillman 3 , C. K. Fairley 2 , J. Roberts 4 , A. Farnsworth 4 , A. E. Grulich 1 , on behalf of the SPANC Research Team; 1 Kirby Inst., Univ. of New South Wales, Sydney, Australia, 2 Univ. of Mel- bourne, Melbourne, Australia, 3 Univ. of Sydney, Sydney, Australia, 4 Douglass Hanly Moir, Sydney, Australia. L2-302 Oropharyngeal Squamous Cell Carcinoma and Human Papillomavirus-Associated Cancers in Women J. Guillet 1 , S. Bevilacqua 2 , P. Bravetti 3 , J. Merlin 4 , T. May 2 , G. Dolivet 1 ; 1 Ctr. Alexis Vautrin, Vandoeuvre Les Nancy, France, 2 CHU Nancy, Van- doeuvre Les Nancy, France, 3 Faculté d’Odontologie, Nancy, France, 4 Faculté Pharmacie, Nancy, France. L2-303 Antimicrobial Susceptibility and Molecular Characterization of Neisseria gonorrhoeae Strains Isolated in 2011 from Barcelona, Spain J. Serra 1 , G. Roig 2 , R. Juve 3 , J. Gonzalez-Lopez 1 , C. Paz, Technician 1 , D. Viu, Technician 1 , A. Andreuer 1 , M. Barberà 4 ; 1 Hosp. Vall d’Hebron, Barcelona, Spain, 2 Manso Primary Care Ctr., Barcelona, Spain, 3 Manso Primary Care Ctr. 2, Barcelona, Spain, 4 Sexually Transmitted Infectious Unit, Barcelona, Spain. L2-304 Evaluation of HPV Infection in Adolescent Girls Aged 13-19 Years

S. Esposito